Summary
Patients identified cases where AI scribes confused diagnoses, substituted similarly named medicines or omitted prescription instructions that clinicians had missed. Twenty-seven AI scribes are in use across England, while the MHRA does not classify the tools as medical devices for nationwide oversight.
Why it matters
The findings expose the gap between rapid clinical deployment and the governance, review processes and accountability needed for generated medical records.
Related coverage
- Infostealer malware hijacks Claude sessions
- Cloudflare launches continuously retrained bot-defence engine